CompanyDeals

Mindray Bio-Medical Re-Files for Hong Kong Listing After Initial Application Expiration

CompanyDrug

Ribo Life Science Files EMA Application for Vortosiran Phase IIb Study in Venous Thromboembolism Prevention

Haisco Pharmaceutical's Sishujing Seeks Postoperative Pain Indication, Expanding Peripheral Kappa Agonist Franchise
CompanyDrug

Haisco Pharmaceutical’s Sishujing Seeks Postoperative Pain Indication, Expanding Peripheral Kappa Agonist Franchise

Daiichi Sankyo Unveils Ambitious Five-Year Plan Targeting $19B Revenue and Top-Five Global Oncology Position
Company

Daiichi Sankyo Unveils Ambitious Five-Year Plan Targeting $19B Revenue and Top-Five Global Oncology Position

Juventas Cell Therapy's CAR-T Yuanruida Seeks Pediatric ALL Indication, Expanding China's Only Dual-Malignancy CAR-T Franchise
CompanyDrug

Juventas Cell Therapy’s CAR-T Yuanruida Seeks Pediatric ALL Indication, Expanding China’s Only Dual-Malignancy CAR-T Franchise

CompanyDrug

Hengrui and Braveheart Bio Report Positive Phase 2 Results for Next-Gen Cardiac Myosin Inhibitor HRS-1893 in Non-Obstructive HCM

CompanyDeals

Akari Therapeutics Partners with WuXi XDC to Advance Novel PH1 Payload Platform for Urothelial Cancer

Policy / Regulatory

NMPA Releases 105th Batch of Generic Drug Reference Standards, Adding 37 New Specifications

CompanyDeals

China Medical System Secures Exclusive China Rights to Pharmacosmos’ MonoFer and CosmoFer IV Iron Therapies

Yifan Pharmaceutical Licenses Ryzneuta to French Distributor Intsel Chimos for Exclusive Commercialization
CompanyDeals

Yifan Pharmaceutical Licenses Ryzneuta to French Distributor Intsel Chimos for Exclusive Commercialization

Hybio Pharmaceutical Expands Torrent Pharma Partnership with Lanreotide Acetate for U.S. Market
CompanyDeals

Hybio Pharmaceutical Expands Torrent Pharma Partnership with Lanreotide Acetate for U.S. Market

Hybio Pharmaceutical Licenses GLP-1 Copycats to MCG Pharma for Exclusive Turkish Commercialization
CompanyDeals

Hybio Pharmaceutical Licenses GLP-1 Copycats to MCG Pharma for Exclusive Turkish Commercialization